Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Remdesivir
nsp14
Approved by FDA Experimental Antiviral Jan/18/2023
Ritonavir
nsp14
Emergency use authorization Used to treat other disease Antiviral Nov/02/2021
Baicalein
nsp14
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Grazoprevir
nsp14
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/31/2021
Nitazoxanide
nsp14
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/16/2021
Hypericin
nsp14
Potential treatment - theoretical effect Natural product Antiviral Mar/08/2021
Pontacyl violet 6R
nsp14
Potential treatment - theoretical effect Experimental Antiviral Jan/21/2021
Paritaprevir
nsp14
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021
Simeprevir
nsp14
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/02/2020
Saquinavir
nsp14
Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/26/2020
Toremifene
nsp14
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Oct/28/2020
Bromocriptine
nsp14
Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/07/2020